Triple Combination Therapy of Choroidal Neovascularization in AMD, a Cost Effect and Efficient Therapeutic Treatment

Exudative Macular Degeneration Clinical Trial

Official title:
Triple Combination Therapy of Choroidal Neovascularization in Exudative Age-related Macular Degeneration - a Cost Effect and Efficient Therapeutic Treatment

Status Completed

Clinical Trial Summary

We propose to undertake a retrospective review of approximately 200 patients with a diagnosis of exudative macular degeneration treated with triple combination therapy (Bevacizumab, Dexamethasone and Photo-dynamic therapy) during the years of 2006 to 2010 at The Retina Center and compare those results with an additional group of approximately 200 patients also treated with triple combination therapy and 20 mg of daily oral zeaxanthin.

Clinical Trial Description

Study parameters will include best corrected visual acuity, number of combination treatments, reduction of central foveal thickness by OCT measurement and development of exudative macular degeneration in the fellow eye. Follow up will include all patients with a minimum of two years. Retrospective review of patient charts in the office of The Retina Center. ;

Study Design

Observational Model: Case Control, Time Perspective: Retrospective

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02287298
Study type	Observational
Source	The Retina Center of St. Louis County, PC
Contact
Status	Completed
Phase	N/A
Start date	August 2014
Completion date	December 2015

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01835067` - Intravitreal tPA and C3F8 for the Treatment of Submacular Haemorrhage as a Complication of Neovascular AMD	Phase 2/Phase 3
Completed	`NCT01674569` - Pilot Study of X-82 in Patients With Wet AMD	Phase 1/Phase 2
Recruiting	`NCT04504123` - MMP-9 Inhibition for Recalcitrant Wet AMD	Phase 2
Completed	`NCT01473251` - Analysis of Growth Factors in Patients Undergoing Lucentis or Avastin Injections for Diabetic Macular Edema and Exudative Macular Degeneration	N/A
Recruiting	`NCT05093374` - Treatment of Neovascular AMD: Artificial Intelligence in Real-world Setting	Phase 4
Completed	`NCT01617148` - Wet Macular Degeneration Study to Compare Ranibizumab or Bevacizumab to Aflibercept	Phase 4
Completed	`NCT01535950` - Safety and Efficacy of Intravitreal LFG316 in Wet Age Related Macular Degeneration (AMD)	Phase 2
Active, not recruiting	`NCT03803631` - CNV in AMD Analyzed by OCT Angiography Under IntravitreaL Eylea (COCTAEyl)